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1. Introduction 
It has recently been shown that the elastolytic ac- 
tivity of elastase (pancreatopeptidase E, EC 3.4.4.7.) 
is inhibited by human cw2-macroglobulin [ 1,2] . Elast- 
ase thus belongs to a class of hydrolytic enzymes (tryp- 
sin, chymotrypsin, thrombin, plasmin) which form 
complexes with cr2-macroglobulin (cy2 M). These com- 
plexes are active against synthetic substrates but in- 
active against proteins; also, the qM-bound enzymes 
are not inhibited by high molecular weight inhibitors 
(see [3] and references therein). It was thus of inter- 
est to see whether the above properties can be extended 
to elastase. 
The results presented in this letter concern the 
effect of human and porcine 02M on porcine elastase. 
The 02M-elastase complexes are inactive against 
Remazol-brilliant-blue elastin but retain approximate- 
ly 80% of the activity of free elastase on t-BOC-alanine- 
p-nitrophenyl ester. One molecule of 02M binds two 
or three molecules of enzyme. The complex between 
human 02M and elastase is only partially protected 
against the inhibition by soybean trypsin inhibitor or 
o1 -antitrypsin. 
2. Materials and methods 
Elastase, an electrophoretically pure preparation 
from Worthington (code ESFF, 64 Sachar Units/mg) 
was dissolved either in 0.05 M N,N-bis(2-hydroxyethyl) 
glycine (bicine) buffer, pH 8.8, for the elastolytic 
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assay or in 0.066 M Soerensen phosphate buffer, pH, 
6.5, for the esterolytic assay. The molar concentra- 
tions of the enzyme solutions were calculated by 
taking 25,000 as the molecular weight of elastase. 
Human or porcine 9M, the generous gifts of Dr. 
Steinbuch [4] and Dr. Jacquot-Armand [S] were 
dissolved in either one of the above buffers. The 
molar concentrations of the 02M solutions were deter- 
mined by using the appropriate absorbance coeffi- 
cients (A’%rcm = 8.1 
2801pn 
and 10.2) and molecular weights 
(820,000 and 960,000). Soybean trypsin inhibitor 
(3 X tryst., Calbiochem, M. W. = 20,000) or human 
serum albumin (4 X tryst., NBCo) were dissolved in 
the phosphate buffer. Human o1 -antitrypsin (M.W. = 
60,000) was a crude preparation obtained by filter- 
ing human plasma on Sephadex G-200. Its concentra- 
tion was determined immunochemically. 
The elastolytic and esterolytic activities were de- 
termined with remazol-brilliant-blue elastin (RBB- 
elastin) [6] and N-terbutyloxycarbonyl-L-alanine-p- 
nitrophenylester (NBA, MANN) [7] respectively. 
Elastase and o2M (or soybean inhibitor or CVI -anti- 
tryspin) were allowed to react for 7 min before the 
residual enzymatic activity was assayed. The experi- 
ments designed to test the inhibition of the esterolytic 
activity of the 02M-elastase complex were conducted as 
follows: elastase was reacted with CQM for 7 min at 25”, 
then soybean inhibitor (or o1 -antitrypsin) was added 
and the residual activity was determined after an addi- 
tional reaction time of 7 min. Controls for non-enzym- 
atic hydrolysis of NBA were run similarly. 
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3. Results and discussion 
In fig. 1, the effects of human and porcine CQM 
on the catalytic activity of elastase using either a 
natural substrate or a synthetic one are compared. 
With RBB-elastin as the substrate, a linear inhibition 
is observed with increasing concentrations of SM. 
The association between %M and elastase isapparent- 
ly non-reversible since the inhibition is stochiometric 
down to 0% activity. This stochiometry may however 
be due to an exceedingly high association constant 
between the two proteins. Elastase:qM ratios at 100% 
inhibition are 0.53 and 0.37 for human and porcine 
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Fig. 1. Influence of porcine and human CQM on the elastoly- 
tic (0) and esterolytic (0) activity of elastase. Elastolytic as- 
say: reaction volume 5 ml; RBB-elastin 4 mg/ml; elastase 
5.9 X 10.‘M; %M 0 to 3.2 X 10-7 M; 0.05 M bicme buffer, 
pH 8.8; 37’. Esterolytic assay: reaction volume 3 ml; NBA 
4 X 10e4 M;elastase 1.33 X lo-’ M;&M 0 to 2.66 X l@‘M; 
0.066 M phosphate buffer pH 6.5 ; 25’. 
%M respectively. To the nearest integer, the molar 
ratios of enzyme to 9M are thus 2: 1 (human 02M) 
and 3: 1 (porcine CY~M). 
When the activity is measured with the synthetic 
substrate, CY~M acts as a partial inhibitor since the 
o12Melastase complexes are 75% or 80% active (fig. 1). 
It should be noticed that in both cases the esterolytic 
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Fig. 2. Inhibition of the esterolytic activity of free and %M- 
bound elastase by soybean trypsin inhibitor (STI) and (Yr-an- 
titrypsin (&AT). Esterolytic assay as indicated in fig. 1. 
A: (~,ATelastase 1.33 X lo-’ M;(rrAT 0 to 2.16 X lo-‘M. 
curve 1: free elastase; 
curves 2 and 3: f&M-elastase same molar ratios 
as for STI. 
B: STI elastase 1.33 X lo-’ M; ST1 0 to 3.99 X 10s6 M; 
curve 1: free elastase: (--) calculated curve; (0) 
experimental points; 
curve 2: @M-elastase: &zM/elastase molar ratio = 
0.5 ; 
curve 3: &M-elastase: @M/elastase molar ratio = 
1.0. 
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activity becomes constant with concentrations of
qM which give 100% inhibition of the elastolytic 
activity. The initial decrease in activity is thus a meas- 
ure of the binding of oZM to elastase. Unlike porcine 
o2M, the human protein activates the esterolytic ac- 
tivity of elastase when the cr2M/elastase molar ratio is 
lower than 0.1 (fig. 1A). This activation has been ob- 
served repeatedly in separate xperiments; besides 
cu2M does not hydrolyze the substrate by itself. It was 
thought hat the initial activation was non-specific; to 
check this hypothesis, human serum albumin (HSA) 
was added to the reaction mixture instead of o12M: a
33% activation was observed with a concentration of 
HSA of 1 .l X 10m2 mgjml. HSA (and probably other 
proteins) may thus induce a conformational change 
of the elastase molecule with a subsequent increase of 
the catalytic activity of the enzyme. For an qM/elas- 
tase molar ratio lower than 0.1, the reaction medium 
contains free elastase and a small proportion of 
o2Melastase complexes: these complexes may exert 
a potentiating effect on the free elastase molecules in 
the same way as does HSA. The non-observable initial 
activation in the case of porcine o12M (fig. 1B) may 
be due to the higher binding capacity of this protein 
which leaves less free enzyme molecules in the reac- 
tion medium. 
Fig. 2 shows the inhibition of the esterolytic acti- 
vity of free elastase and qM-bound elastase by soy- 
bean trypsin inhibitor (STI, fig. 2B) and o1 -antitrypsin 
(oil AT (fig. 2A). Both inhibitors form inactive com- 
plexes with free elastase (100% inhibition was obtained 
with an STI/elastase molar ratio of 50). The data with 
ST1 and free elastase (fig. 2B) were analyzed by assum- 
ing the reversible formation of a one to one enzyme- 
inhibitor complex whose Ki is not affected by the 
presence of substrate. An Easson-Stedman plot [8] 
gave a value of Ki = 6.6 X 10m7 M; the theoretical 
inhibition curve calculated with this value fits well 
the experimental points (fig. 2B). Human serum crl AT 
which inhibits the elastolytic activity of elastase [ 1, 
21 also inhibits the esterolytic activity of this enzyme 
(fig. 2A). Extrapolation of the linear part of the in- 
hibition curve gives an inhibitor:enzyme ratio of 1.11 
at 100% inhibition. It is thus reasonable to conclude 
that one mole of ol AT inhibits one mole of elastase. 
The Ki value, determined by activity measurements near 
the equivalence point was found to be 3.5 X 10-l”M. 
Because 02Melastase does not hydrolyze the macro- 
molecular substrate RBBelastin, it was thought hat 
its esterolytic activity is not inhibited by the macro- 
molecular inhibitors ST1 and ol AT. The results of 
fig. 2 only partially confirm this prediction: with an 
qM/elastase molar ratio of 0.5, ST1 inhibits the 
qMelastase activity to 40% and al AT to 20%. It 
must thus be assumed that these proteins can be 
bound to the cr2M-elastase complex. The differences 
in inhibitory potencies may be related to the differ- 
ences in molecular weights of ST1 (20,000) and ol AT 
(60,000) whose binding to elastase may be more or 
less sterically hindered by 9M. The results obtained 
with a higher concentration of %M (02M/elastase = 1) 
are somewhat contradictory and difficult to inter- 
pret:alAT inhibits less but ST1 inhibits more than 
with the former concentration of 9M. No reasonable 
interpretation was found to account for these discrep- 
ancies. 
In conclusion, our results confii with more quan- 
titative details the inhibition of the elastolytic activity 
of elastase by human 02M demonstrated by others 
[ 1,2] , extend this inhibitory property to porcine 
02M and indicate that o2M does not bind to the cata- 
lytic center of elastase (or does not “bury” it) since 
02M-elastase is able to hydrolyze a small substrate. 
In addition, it is shown that soybean inhibitor and 
al-antitrypsin which inhibit the elastolytic activity 
[ 1,2,9] also abolish the esterolytic activity of free 
elastase and that these proteins can probably form 
ternary complexes with o2M-elastase indicating that 
elastase possesses several protein binding sites. An ex- 
tensive study of these binding properties is now in 
progress. 
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